Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabetes ; 59(8): 2001-9, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20522591

RESUMO

OBJECTIVE: We investigated the mechanisms underlying vascular endothelial and contractile dysfunction in diabetes as well as the effect of HMR1766, a novel nitric oxide (NO)-independent activator of soluble guanylyl cyclase (sGC). RESEARCH DESIGN AND METHODS: Two weeks after induction of diabetes by streptozotocin, Wistar rats received either placebo or HMR1766 (10 mg/kg twice daily) for another 2 weeks; thereafter, vascular function was assessed. RESULTS: Endothelial function and contractile responses were significantly impaired, while vascular superoxide formation was increased in the aortae from diabetic versus healthy control rats. Using RNA microarrays, cytochrome P4502E1 (CYP2E1) was identified as the highest upregulated gene in diabetic aorta. CYP2E1 protein was significantly increased (16-fold) by diabetes, leading to a reduction in levels of the potent vasoconstrictor 20-hydroxy-eicosatetraenoic acid (20-HETE). Induction of CYP2E1 expression in healthy rats using isoniazide mimicked the diabetic noncontractile vascular response while preincubation of aortae from STZ-diabetic rats in vitro with 20-HETE rescued contractile function. Chronic treatment with the sGC activator HMR1766 improved NO sensitivity and endothelial function, reduced CYP2E1 expression and superoxide formation, enhanced 20-HETE levels, and reversed the contractile deficit observed in the diabetic rats that received placebo. CONCLUSIONS: Upregulation of CYP2E1 is essentially involved in diabetic vascular dysfunction. Chronic treatment with the sGC activator HMR1766 reduced oxidative stress, decreased CYP2E1 levels, and normalized vasomotor function in diabetic rats.


Assuntos
Citocromo P-450 CYP2E1/genética , Regulação Enzimológica da Expressão Gênica , Guanilato Ciclase/genética , Guanilato Ciclase/metabolismo , Ácidos Hidroxieicosatetraenoicos/biossíntese , Sulfonamidas/uso terapêutico , ortoaminobenzoatos/uso terapêutico , Animais , Aorta Torácica/metabolismo , Aorta Torácica/fisiopatologia , Diabetes Mellitus Experimental/tratamento farmacológico , Angiopatias Diabéticas/enzimologia , Angiopatias Diabéticas/genética , Guanilato Ciclase/uso terapêutico , Humanos , MicroRNAs/genética , Análise de Sequência com Séries de Oligonucleotídeos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Espécies Reativas de Oxigênio/metabolismo , Superóxidos/metabolismo , Regulação para Cima , Vasodilatação/efeitos dos fármacos
2.
Thromb Res ; 122(1): 59-68, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-17931695

RESUMO

INTRODUCTION: Identification of the full content of platelet proteins and their mRNAs would be helpful for further studies of human platelet function. For this purpose, proteomic as well as transcriptomic methods (SAGE and qRT-PCR) can be utilized, but the purity of the platelet samples studied is crucial. Here we report the development of a new, effective, and efficient technique for purification of human platelets from washed apheresis platelet concentrates and whole blood. MATERIALS AND METHODS: Methods used are a combination of differential and gradient centrifugation steps. The level of purification was determined by nephelometry, FACS, and PCR. RESULTS: We could show that even the P2Y purinoceptor 12 (P2Y(12)) receptor, which undergoes rapid homologous desensitization, was still functional after the purification procedure. The presence of PINCH (particularly interesting new Cys-His protein) and alpha-parvin, which constitute the IPP (ILK-PINCH-parvin) complex together with the integrin-linked kinase (ILK), has been predicted in platelets by proteomic analysis. We could confirm this observation with our purified platelets. Detection of these proteins is an example of the application of this purification protocol that can be used for the verification of proteins postulated by high-throughput studies. CONCLUSIONS: The procedure for obtaining purified platelets described here provides an essential, much-needed tool for the comprehensive investigation of platelet proteins and functions.


Assuntos
Plaquetas/metabolismo , Proteínas Sanguíneas/genética , Actinina/sangue , Actinina/genética , Proteínas Adaptadoras de Transdução de Sinal , Proteínas Sanguíneas/isolamento & purificação , Separação Celular/métodos , Proteínas de Ligação a DNA/sangue , Proteínas de Ligação a DNA/genética , Perfilação da Expressão Gênica , Antígenos HLA-DQ/genética , Humanos , Proteínas com Domínio LIM , Antígenos CD15/sangue , Antígenos CD15/genética , Proteínas de Membrana , Proteínas dos Microfilamentos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de von Willebrand/genética
3.
Thromb Haemost ; 95(4): 643-51, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16601835

RESUMO

A comprehensive SAGE (serial analysis of gene expression) library of purified human platelets was established. Twenty-five thousand (25,000) tags were sequenced, and after removal of mitochondrial tags, 12,609 (51%) non-mitochondrial-derived tags remained, corresponding to 2,300 different transcripts with expression levels of up to 30,000 tags per million. This new, highly purified SAGE library of platelets is enriched in specific transcripts. The complexity in terms of tag distribution is similar to cells that are still able to replenish their mRNA pool by transcription. We show that our SAGE data are consistent with recently published microarray data but show further details of the platelet transcriptome, including (i) longer UTR regions and more stable folding in the enriched mRNAs, (ii) biologically interesting new candidate mRNAs that show regulatory elements, including elements for RNA stabilization or for translational control, and (iii) significant enrichment of specific, highly transcribed mRNAs compared to a battery of SAGE libraries from other tissues. Among several regulatory mRNA elements known to be involved in mRNA localization and translational control, CPE elements are in particular enriched in the platelet transcriptome. mRNAs previously reported to be translationally regulated were found to be present in the library and were validated by real-time PCR. Furthermore, specific molecular functions such as signal transduction activity were found to be significantly enriched in the platelet transcriptome. These findings emphasize the richness and diversity of the platelet transcriptome.


Assuntos
Plaquetas/metabolismo , Perfilação da Expressão Gênica/métodos , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Proteômica/métodos , Regiões 3' não Traduzidas , Regiões 5' não Traduzidas , Análise por Conglomerados , Interpretação Estatística de Dados , Etiquetas de Sequências Expressas , Humanos , RNA/metabolismo , Processamento Pós-Transcricional do RNA , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Termodinâmica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...